These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34495438)

  • 1. sABLATE: a simplified ABLATE score for prediction of complications and outcome in percutaneous thermal ablation of renal lesions.
    Papa M; Biondetti P; Colombo R; Ierardi AM; Angileri SA; Lucignani G; Boeri L; Montanari E; Cardone G; Scagnelli P; Carrafiello G
    Med Oncol; 2021 Sep; 38(10):126. PubMed ID: 34495438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions.
    Papa M; Suardi N; Losa A; Agostini G; Maga T; Ierardi AM; Carrafiello G; Gaboardi F; Cardone G
    Med Oncol; 2020 Mar; 37(4):26. PubMed ID: 32166542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the RENAL and mRENAL Scores and the Relative Importance of Their Components in the Prediction of Complications and Local Progression after Percutaneous Renal Cryoablation.
    Mouli SK; McDevitt JL; Su YK; Ragin AB; Gao Y; Nemcek AA; Lewandowski RJ; Salem R; Sato KT
    J Vasc Interv Radiol; 2017 Jun; 28(6):860-867. PubMed ID: 28291714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores.
    Efthymiou E; Velonakis G; Charalampopoulos G; Mazioti A; Brountzos E; Kelekis N; Filippiadis D
    Eur Radiol; 2023 Nov; 33(11):7388-7397. PubMed ID: 37318604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.
    De Cobelli F; Papa M; Panzeri M; Colombo M; Steidler S; Ambrosi A; Cao R; Gusmini S; Marra P; Capitanio U; Bertini R; Venturini M; Losa A; Gaboardi F; Montorsi F; Cardone G
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):76-83. PubMed ID: 31451888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
    Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
    Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the ability of the mRENAL nephrometry score to identify patients at risk for major adverse events or local tumor recurrence after percutaneous renal cryoablation.
    Allen DM; Babar T; GloryAkinduro O; Li M; Khudari HE; Gunn AJ
    Abdom Radiol (NY); 2024 Aug; ():. PubMed ID: 39150544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
    Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
    Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
    Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
    AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
    Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT
    AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous cryoablation of masses in a solitary kidney.
    Weisbrod AJ; Atwell TD; Frank I; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
    AJR Am J Roentgenol; 2010 Jun; 194(6):1620-5. PubMed ID: 20489104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome?
    Martin J; Athreya S
    Diagn Interv Radiol; 2013; 19(6):501-7. PubMed ID: 24084196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.